Graphene Investments SAS’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.74M Buy
9,600
+2,700
+39% +$1.14M 2.18% 11
2026
Q1
$3.27M Hold
6,900
2.19% 11
2025
Q4
$3.22M Sell
6,900
-1,200
-15% -$557K 2.02% 28
2025
Q3
$3.45M Hold
8,100
2.18% 11
2025
Q2
$3.1M Hold
8,100
2.02% 21
2025
Q1
$2.8M Sell
8,100
-1,400
-15% -$450K 2.04% 24
2024
Q4
$2.85M Buy
9,500
+1,600
+20% +$559K 1.97% 34
2024
Q3
$3.21M Sell
7,900
-2,600
-25% -$952K 2.06% 17
2024
Q2
$3.37M Hold
10,500
2.12% 12
2024
Q1
$3.5M Buy
+10,500
New +$3.21M 2.11% 15

Other funds holding HCA

Graphene Investments SAS's HCA Position: Q2 2026 in Review

Graphene Investments SAS increased its HCA Healthcare (HCA) stake by 39% in Q2 2026, buying an estimated $1.14M and bringing the position to 9,600 shares worth $3.74M. The position accounts for 2.18% of the portfolio, ranked #11.

Graphene Investments SAS first reported a position in HCA in Q1 2024 and has held it in 10 quarters since. 342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Graphene Investments SAS held 9,600 shares of HCA Healthcare worth $3.74M as of Q2 2026.
  • Graphene Investments SAS bought 2,700 HCA Healthcare shares in Q2 2026, an estimated $1.14M.
  • HCA Healthcare made up 2.18% of Graphene Investments SAS's portfolio in Q2 2026, its #11 holding.
  • Graphene Investments SAS first reported a position in HCA Healthcare in Q1 2024 and has held it in 10 quarters since.
  • 342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Graphene Investments SAS's 13F filing for Q2 2026, filed 20 Jul 2026.